Rensselaer Polytechnic Institute graduating senior Jeffery Martin has put his basic knowledge of sugars to exceptional use by creating a lab-on-a-chip device that builds complex, highly specialized sugar molecules, mimicking one of the most important cellular structures in the human body - the Golgi Apparatus.

Among the most important and complex molecules in the human body, sugars control not just metabolism but also how cells communicate with one another.

Cells build sugars in a cellular organelle known as the Golgi Apparatus. Under a microscope, the Golgi looks similar to a stack of pancakes. The strange-looking organelle finishes the process of protein synthesis by decorating the proteins with highly specialized arrangements of sugars. The final sugar-coated molecule is then sent out into the cell to aid in cell communication and to help determine the cell’s function in the body.

CALGARY, Canada, May 7 /PRNewswire/ -- Addax Petroleum Corporation ("Addax Petroleum" or the "Corporation") (TSX: AXC and LSE: AXC), announces that Mr. Jean Claude Gandur, President and Chief Executive Officer, will be presenting at the Tristone Capital Energie'08 Conference in Paris on Tuesday May 13th, 2008 at approximately 2:55 p.m. local time (1:55 p.m. London U.K. Time / 8:55 a.m. Eastern Time).

Investors are invited to use the link below to watch the presentation and listen to the live audio cast. To enroll for the event, click on the Large Cap E+P box and then click "Enroll". Follow-up emails will indicate how to join the event.

https://tristonecapital-ls.webex.com/tristonecapital-ls/onstage/g.php?p=...

SAO PAULO, Brazil, May 7 /PRNewswire/ --

BRASKEM S.A. (BOVESPA: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK), the leading company in the thermoplastic resins industry in Latin America and third-largest resins producer in the Americas, announces today its results for the first quarter of 2008 (1Q08).

Main highlights of the period: -- Domestic resin sales grew 7% in 1Q08 -- Resins production reached 704,000 tons in 1Q08 -- Fixed expenses reduction in 1Q08 -- Over R$77 million in synergies captured until 1Q08 -- EBITDA reaches R$583 million in 1Q08 -- Braskem inaugurates Paulinia unit -- Conclusion of the acquisition of the petrochemical assets of the Ipiranga Group -- Conclusion of sale of its stake at Petroflex -- Green Polymer Project moves forward

TORONTO, May 7 /PRNewswire/ -- Apotex Inc., Canada's largest generic pharmaceutical company has successfully bid and been awarded a tender from the Rwandan Government for the life saving triple combination AIDS drug "Apo Triavir". Apotex is the first company to provide this medicine to Africa under the provisions of the Canadian Access to Medicines Regime (CAMR).

The CAMR provides a mechanism for developing countries to address critical healthcare needs by importing less expensive generic versions of patented drugs. Following the process it has taken Apotex over three years to get to this point where a drug can go to thousands in Africa.

SAN DIEGO, May 7 /PRNewswire/ --

- New Member Complements Board With Significant Financial and Operational Expertise -

Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today the appointment of John Varian to the company's board of directors. Mr. Varian currently serves as the chief operating officer and chief financial officer of Aryx Therapeutics, a pharmaceutical company focused on the discovery and development of oral therapeutics for chronic disease.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080303/LAM023LOGO)

LONDON, May 7 /PRNewswire/ --

- Astadia Gains Momentum in 2008 and Continues Providing SaaS Solutions to Assist Collaboration Across Teams and Organisations

LONDON, May 7 /PRNewswire/ --

- David Sayers Named Finance Director of Bournemouth and West Hampshire Water

Cascal N.V. (NYSE: HOO), a leading provider of water and wastewater services in seven countries, today announced the appointment of Jonathan Lamb as General Counsel and Company Secretary (subject to formal Board approval). Mr. Lamb replaces David Sayers, who has been named Finance Director of Cascal's UK subsidiary, Bournemouth and West Hampshire Water.

STAINES, England, May 7 /PRNewswire/ -- The European Medicines Agency (EMEA) has announced the marketing authorisation of Mycamine(R), Astellas Pharma Europe's treatment for invasive candidiasis, oesophageal candidiasis and prophylaxis of Candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation. Mycamine(R) will initially be available in the U.K and across the European market shortly after this.

ORSK, Russia, May 7 /PRNewswire/ --

Mechel OAO (NYSE: MTL), one of the leading Russian mining and metals companies, announces that its subsidiary, Southern Urals Nickel Plant OAO, and Bateman Engineering have signed a contract on the construction of a new melting complex for Mechel's nickel plant.

The contract, which is signed in accordance with the investment program of Southern Urals Nickel Plant, provides fundamental re-equipment of the plant and includes the design and supply of a 12 MW DC furnace. The furnace will be erected at Southern Urals Nickel's existing facility. The total project value is US$31 million.

EDINBURGH, Scotland and LEBANON, New Hampshire, May 7 /PRNewswire/ --

- Shorter Run Times, Faster Data Analysis, Rapid Visualization

DEM Solutions today announce the latest release of EDEM that will set a new benchmark in particle simulation modeling software. Already offering the most advanced graphic user interface, EDEM 2.0 is now the fastest and most highly parallelized Discrete Element Modeling software on the market, providing users with increased scope and scale of particle simulation applications.